Literature DB >> 9709748

Arterial macroaneurysms in peripheral multifocal chorioretinitis associated with sarcoidosis.

A Rothova1, C Lardenoye.   

Abstract

OBJECTIVE: This study aimed to describe the clinical presentation, angiographic findings, and natural history of acquired arterial macroaneurysms diagnosed in 8 of 48 patients with peripheral multifocal chorioretinitis (PMC) (panuveitis with multiple peripheral punched-out chorioretinal lesions).
DESIGN: A retrospective case-control study. PARTICIPANTS: Forty-eight consecutive patients with PMC, consisting of 13 patients with histologically or radiologically proven sarcoidosis, 11 with laboratory evidence of (presumed) sarcoidosis, and 24 with no evidence of systemic disease, participated in the study. INTERVENTION: A review of the clinical, photographic, and angiographic records was performed. MAIN OUTCOME MEASURES: Arterial macroaneurysms, clinical symptoms, and associations with systemic disease were measured.
RESULTS: Of 48 patients with PMC, 8 (17%) had arterial macroaneurysms: 3 (38%) of 8 with histologically proven sarcoidosis, 1 (20%) of 5 with radiologically proven sarcoidosis, 2 (18%) of 11 with laboratory evidence of sarcoidosis, and 2 (8%) of 24 patients with no evidence of systemic sarcoidosis. All eight patients were white females older than 60 years of age. Macroaneurysms appeared to be unrelated to the systemic hypertension (5 of 17 compared to 3 of 31; P = 0.11); however, the frequency of cerebrovascular accidents or myocardial infarctions was higher among those with macroaneurysms (5 of 8 vs. 2 of 40; P = 0.0000). Three of the eight patients reported visual complaints related to macroaneurysms; only one patient required laser treatment. Fluorescein angiography showed no evidence of previous vasculitis in the involved area.
CONCLUSIONS: Arterial macroaneurysms, which occur in elderly female patients with PMC, are associated with severe cardiovascular disease. Whether the macroaneurysms are a complication of an inflammatory vascular process remains speculative.

Entities:  

Mesh:

Year:  1998        PMID: 9709748     DOI: 10.1016/S0161-6420(98)98018-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Diagnostic and therapeutic challenges.

Authors:  Luiz H Lima; Eric Shakin; Hatice N Sen; Robert B Nussenblatt; Lawrence A Yannuzzi; Lee M Jampol; Emmett T Cunningham
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

3.  Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography.

Authors:  Christopher Eckstein; Shiv Saidha; Elias S Sotirchos; Gita Byraiah; Michaela Seigo; Aleksandra Stankiewicz; Stephanie B Syc; E'tona Ford; Srilakshmi Sharma; Peter A Calabresi; Carlos A Pardo
Journal:  J Neurol       Date:  2012-01-04       Impact factor: 4.849

4.  Sarcoidosis in the national veteran population: association of ocular inflammation and mortality.

Authors:  Andrea D Birnbaum; Dustin D French; Mehdi Mirsaeidi; Sarah Wehrli
Journal:  Ophthalmology       Date:  2015-02-14       Impact factor: 12.079

5.  Differential diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

6.  Features of retinal arterial macroaneurysms in patients with uveitis.

Authors:  E Yamanaka; N Ohguro; A Kubota; S Yamamoto; Y Nakagawa; Y Tano
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

7.  Gallium scintigraphy in the investigation of retinal inflammatory vasculopathy.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Robert B Nussenblatt; Chloe C Gottlieb; Emily Y Chew; Wai T Wong
Journal:  Acta Ophthalmol       Date:  2010-11       Impact factor: 3.761

Review 8.  A clinical approach to the diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Int Ophthalmol       Date:  2009-02-04       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.